We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.62%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$112B
AUM Growth
+$936M
(+0.84%)
Cap. Flow
-$1.26B
Cap. Flow
% of AUM
-1.13%
Top 10 Holdings %
Top 10 Hldgs %
31.26%
Holding
4,289
New
46
Increased
1,994
Reduced
1,731
Closed
73
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXE
Expand Energy Corp
EXE
|
+$56.7M |
| 2 |
Apollo Global Management
APO
|
+$36.8M |
| 3 |
Boeing
BA
|
+$34.1M |
| 4 |
Workday
WDAY
|
+$31.9M |
| 5 |
DOCU
DocuSign
DOCU
|
+$26.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$136M |
| 2 |
NVIDIA
NVDA
|
+$110M |
| 3 |
Microsoft
MSFT
|
+$84.1M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$48.4M |
| 5 |
XYZ
Block Inc
XYZ
|
+$44.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.97% |
| 2 | Financials | 13.53% |
| 3 | Consumer Discretionary | 11.77% |
| 4 | Healthcare | 10.06% |
| 5 | Industrials | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
LanzaTech
LNZA
$69.8M
| $109K | ﹤0.01% |
797
+21
| +3% | +$3.15K |
|
|
SUBC
3177
DELISTED
SUBSEA 7 S A SPONSORED ADR
SUBC
| $109K | ﹤0.01% |
6,859
+330
| +5% | +$5.23K |
|
3178
Alto Neuroscience
ANRO
$1.11B
| $108K | ﹤0.01% |
25,556
+5,008
| +24% | +$31.3K |
|
3179
Sanara MedTech
SMTI
$313M
| $107K | ﹤0.01% |
3,231
+112
| +4% | +$3.8K |
|
3180
Acrivon Therapeutics
ACRV
$74M
| $107K | ﹤0.01% |
17,755
-5
| -0% | -$36 |
|
|
ALMS
3181
Alumis Inc
ALMS
$3.52B
| $107K | ﹤0.01% |
13,594
+290
| +2% | +$2.91K |
|
3182
Pyxis Oncology
PYXS
$236M
| $106K | ﹤0.01% |
67,851
+3,423
| +5% | +$9.87K |
|
3183
Brookfield Asset Management
BAM
$83.8B
| $105K | ﹤0.01% |
1,937
+78
| +4% | +$4.21K |
|
|
BRFS
3184
DELISTED
BRF SA
BRFS
| $105K | ﹤0.01% |
25,735
-3,106
| -11% | -$13.5K |
|
3185
Sonida Senior Living
SNDA
$1.91B
| $103K | ﹤0.01% |
4,444
+1,320
| +42% | +$32.4K |
|
3186
Bank of Montreal
BMO
$127B
| $102K | ﹤0.01% |
1,049
+146
| +16% | +$13.8K |
|
3187
JFrog
FROG
$10.8B
| $102K | ﹤0.01% |
3,459
| – | – |
|
|
KWY
3188
Kingsway Corp
KWY
$293M
| $101K | ﹤0.01% |
12,104
-1,734
| -13% | -$15.2K |
|
3189
Valhi
VHI
$450M
| $101K | ﹤0.01% |
4,325
+469
| +12% | +$13.9K |
|
3190
Stereotaxis
STXS
$141M
| $98.6K | ﹤0.01% |
43,234
+285
| +0.7% | +$596 |
|
3191
Emergent Biosolutions
EBS
$248M
| $97.9K | ﹤0.01% |
10,239
-2,011
| -16% | -$18.5K |
|
3192
Rogers Communications
RCI
$18.6B
| $97.4K | ﹤0.01% |
3,169
| – | – |
|
3193
Kyverna Therapeutics
KYTX
$484M
| $96.9K | ﹤0.01% |
25,920
+6,153
| +31% | +$29.5K |
|
|
HLVX
3194
DELISTED
HilleVax
HLVX
| $96.3K | ﹤0.01% |
46,528
-2,273
| -5% | -$4.27K |
|
3195
Rekor Systems
REKR
$91.7M
| $95.8K | ﹤0.01% |
61,435
+7,315
| +14% | +$7.59K |
|
3196
Cemex
CX
$16.3B
| $95.3K | ﹤0.01% |
16,899
-93
| -0.5% | -$528 |
|
|
MOMO
3197
Hello Group
MOMO
$866M
| $94.7K | ﹤0.01% |
12,282
+520
| +4% | +$3.69K |
|
|
LNAI
3198
Lunai Bioworks
LNAI
$10.9M
| $94.4K | ﹤0.01% |
1,412
+778
| +123% | +$51.6K |
|
3199
Zura Bio
ZURA
$566M
| $94.1K | ﹤0.01% |
37,657
+10,231
| +37% | +$36.4K |
|
|
RGLS
3200
DELISTED
Regulus Therapeutics
RGLS
| $94.1K | ﹤0.01% |
59,531
-14,964
| -20% | -$23K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2024 Portfolio in Review
As of Q4 2024, RhumbLine Advisers held 4,289 positions worth $112B, up 0.84% from $111B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 2.8%. RhumbLine Advisers opened 46 new positions and exited 73, leaving the 4,289-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q4 2024 buy was Expand Energy Corp: 614,703 shares worth $61.2M.
- RhumbLine Advisers added most to Apollo Global Management in Q4 2024, an estimated $36.8M increase.
- RhumbLine Advisers's biggest Q4 2024 reduction was Apple, cutting an estimated $136M.
- RhumbLine Advisers fully exited Block Inc in Q4 2024, selling an estimated $44.9M.
- RhumbLine Advisers's ten largest holdings make up 31% of its $112B portfolio in Q4 2024.
- RhumbLine Advisers opened 46 new positions and closed 73 in Q4 2024.
- RhumbLine Advisers's portfolio value rose 0.84% quarter-over-quarter to $112B.
Based on RhumbLine Advisers's 13F filing for Q4 2024, filed 30 Jan 2025.